Washington Administrative Code
Title 182 - Health Care Authority
PRESCRIPTION DRUG PROGRAMS
Chapter 182-50 - Prescription drug programs
Section 182-50-005 - Definitions

(1) "Appointing authority" means the following people acting jointly: The director of the health care authority and the director of the department of labor and industries.

(2) "Committee" means the independent Washington state pharmacy and therapeutics committee created by RCW 41.05.021(1)(b)(iii) and 70.14.050. At the election of the health care authority, the committee may serve as the drug use review board provided for in WAC 182-530-4000.

(3) "Drug" means the term as it is defined in RCW 69.41.010.

(4) "Endorsing practitioner" means a practitioner who has notified the health care authority that he or she agrees to allow therapeutic interchange .

(5) "Practitioner" means a health care provider, except a veterinarian, as defined at RCW 18.64.011.

(6) "Preferred drug" means a drug selected by the appointing authority for inclusion in the Washington preferred drug list used by applicable state agencies for state purchased health care programs.

(7) "Prescription" has the meaning set forth in RCW 18.64.011.

(8) "Refill" means the continuation of therapy with the same drug, including the renewal of a previous prescription or adjustments in dosage.

(9) "State purchased health care" has the meaning set forth in RCW 41.05.011.

(10) "Therapeutic interchange" means to dispense a preferred drug in place of a prescribed nonpreferred drug within the same therapeutic class listed on the Washington preferred drug list.

(11) "Washington preferred drug list" or "WPDL" means the list of drugs selected by the appointing authority to be used by applicable state agencies as the basis for the purchase of drugs in state purchased health care programs.